Tg Sanità, edition of 14 May 2024

We talk about differentiated autonomy, Fentanyl alarm, AstraZeneca vaccines, birth rate and innovative drugs

DIFFERENTIATED AUTONOMY. SCHILLACI: WE WILL NOT LEAVE ANY REGION BEHIND

“We reiterate our desire to help the Regions, ensuring that no one is ever left behind”. This is how the Minister of Health, Orazio Schillaci, responded when asked by journalists about the bill on differentiated autonomy, on the sidelines of the inauguration of the ‘Race for Cure 2024′ Health Village at the Circus Maximus. The differentiated autonomy, the minister said during the last question time in the Chamber, “does not call into question the unity of the right to health protection” but “represents a strengthening of the Regions’ power to modulate their own organization of health services in compliance with the LEAs”.

FENTANYL. MANTOVANO: BEWARE OF DARK AND DEEP WEB. TAJANI: FIGHTING ADDICTIONS PRIORITY

“Fentanyl is mostly ‘peddled’ via the internet, especially on Chinese sites, with delivery by post and payment with cryptocurrencies to make them untraceable. This should make everyone – parents, women and families – more attentive, so that teenagers avoid using these sites.” Thus the undersecretary to the Prime Minister, Alfredo Mantovano, during the press conference on the update of the activities envisaged by the national prevention plan against the improper use of Fentanyl and other synthetic opioids at Palazzo Chigi. “In perfect harmony with our international allies – continued the deputy prime minister and foreign minister, Antonio Tajani – we are working to combat the use of synthetic drugs”.

INNOVATIVE DRUGS. NISTICÒ (AIFA): WORKING TO REDUCE ACCESS TIMES

“We are working to reduce the times of access procedures through a process of de-bureaucratization and administrative simplification which must guarantee citizens the most rapid usability of truly innovative medicines”. The president of AIFA, Robert Nisticò, said this at the end of the first meeting with the president of Farmindustria, Marcello Cattani, which took place last week in Rome. “A constructive and immediately operational discussion – continued Nisticò – which led to the establishment of a technical working group which will have the task of identifying simplification tools, which allow priority to be given to the approval of drugs capable of improving quality of the treatments and therapeutic options available”.

VACCINES. ASTRAZENECA WITHDRAWS ANTI-COVID DOSES ALL OVER THE WORLD

The pharmaceutical company AstraZeneca has announced that it has started the procedures for the worldwide recall of doses of its vaccine against Covid-19. The decision comes after admissions made by the company’s lawyers in court in London in the lawsuit brought by relatives of some British citizens who died from blood clots. “It can cause a very rare side effect with potentially fatal complications,” were the words of the lawyers pronounced in the courtroom, referring to the risk of thrombosis. An admission which, according to the British media, exposes the Anglo-Swedish company to the risk of having to grant multi-million dollar compensation to the families of the victims.

BIRTH. VAIA: STRENGTHENING MATERNITY POLICIES, POSITIVE REPERCUSSIONS ON COMMUNITY HEALTH

“Strengthening policies to protect maternity would also have positive repercussions on the health of citizens, in addition to those on the demographic trend which, as repeatedly reported, increasingly sees us as a ‘country for old people’”. The director general of Prevention of the Ministry of Health, Francesco Vaia, writes this in an in-depth analysis in the ‘Avanti Donne’ newsletter of the Marisa Bellisario Foundation. “We cannot and must no longer allow – added Vaia – that in a woman’s life the choice of motherhood conflicts with the equally right and necessary choice of her own professional fulfillment”.

PHYSIOTHERAPY. GIS FRPP AIFI: ESSENTIAL FOR THE TREATMENT OF PELVI-PERINEAL DYSFUNCTIONS

“Physiotherapy is an essential strategy for the treatment of pelvic-perineal dysfunctions”. This is what the physiotherapists made known on the occasion of the second Conference of the GIS Physiotherapy and Rehabilitation of the Pelvic Floor (GIS FRPP) of the Italian Association of Physiotherapy (AIFI) which took place in Bologna. “Open to physiotherapists, physiotherapy students and doctors – commented Dr. Elia Bassini, president of the GIS FRPP – the event represented an opportunity for discussion between national and international physiotherapists on areas of great interest for pelvic floor physiotherapy” .